Considering that increased expression of PME-1 and increased demethylation of PP2A have been found in brain tissue of individuals with AD [4], and PP2A methylation has been shown to decrease in the aging brain [5], these findings could hold clinical significance for AD treatment or other age-related brain disorders. Here, PTPA is linked to Alzheimer disease.